Announce Date | 02/27/2025 |
EPS Normalized Actual | $0.13 (Miss by $-0.08) |
EPS GAAP Actual | $0.13 (Miss by $-0.08) |
Revenue Actual | $0.60772B |
Revenue Surprise | Beat by $607.72M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.36 |
EPS GAAP Estimate | $0.36 |
Revenue Estimate | $1.5207075B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 1.15 | 22.87 | 1.085 | 1.24594 | 1 |
Dec 2025 | 1.2 | 21.92 | 1.2 | 1.2 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.11 | -0.1575 | 0.60772B | -0.09% | -3.64M |
FQ3 2024 (Sep 2024) | 0.19 | -0.07 | 0.603125B | 0.06% | -3.64M |
FQ2 2024 (Jun 2024) | -0.25 | -1.59259 | 0.607185B | 2.19% | -580.6M |
FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 0.605672B | -0.42% | 605.67M |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 0.608283B | -2.04% | 608.28M |
FQ3 2023 (Sep 2023) | 0.17 | 0.17 | 0.602785B | -2.31% | 602.79M |
FQ2 2023 (Jun 2023) | 0.24 | 0.24 | 0.593891B | 0.96% | 593.89M |
FQ1 2023 (Mar 2023) | 0.19 | 0.19 | 0.608209B | 100% | 608.21M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.36
Consensus Revenue Estimates
1.5207075B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.34 | -- | 1.29692 | 1.3991 | 1 |
FQ3 2026 (Sep 2026) | 1.35 | -- | 1.3066 | 1.40954 | 1 |
FQ2 2026 (Jun 2026) | 1.31 | -- | 1.26788 | 1.36777 | 1 |
FQ1 2026 (Mar 2026) | 1.19 | -- | 1.15174 | 1.24248 | 1 |
FQ4 2025 (Oct 2025) | 0.39 | 71.79 | 0.3862 | 0.39202 | 2 |
FQ3 2025 (Jul 2025) | 0.38 | 50 | 0.3763 | 0.38197 | 2 |
FQ2 2025 (Jun 2025) | 0.36 | 169.44 | 0.35729 | 0.36239 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.02B | -- | 1B | 1.06B | 2 |
FQ3 2026 (Sep 2026) | 1.02B | -- | 0.99B | 1.05B | 2 |
FQ2 2026 (Jun 2026) | 1B | -- | 0.98B | 1.03B | 2 |
FQ1 2026 (Mar 2026) | 0.96B | -- | 0.94B | 1B | 2 |
FQ4 2025 (Oct 2025) | 0.64B | 4.5 | 0.63B | 0.64B | 1 |
FQ3 2025 (Jul 2025) | 0.63B | 4.82 | 0.63B | 0.64B | 1 |
FQ2 2025 (Jun 2025) | 1.52B | 60.07 | 1.51B | 1.53B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.2675 | 0.11 | -0.1575 | -143.18% |
FQ3 2024 (Sep 2024) | 0.26 | 0.19 | -0.07 | -36.84% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.25 | -1.59259 | 637.04% |
FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 100% | |
FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% | |
FQ3 2023 (Sep 2023) | 0.17 | 0.17 | 100% | |
FQ2 2023 (Jun 2023) | 0.24 | 0.24 | 100% | |
FQ1 2023 (Mar 2023) | 0.19 | 0.19 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.61B | $0.61B | $-3.64M | -0.6% |
FQ3 2024 (Sep 2024) | $0.61B | $0.6B | $-3.64M | -0.6% |
FQ2 2024 (Jun 2024) | $1.19B | $0.61B | $-580.6M | -95.62% |
FQ1 2024 (Mar 2024) | $0B | $0.61B | $605.67M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.61B | $608.28M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.6B | $602.79M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.59B | $593.89M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.61B | $608.21M | 100% |